Synlico
Company Details
Status: Private
Employees: 1-10
Location:
South San Francisco, California, United States
Type:
sample
Technology:
sample
sample
sample
sample
About: Synlico Inc. is a resident company of Johnson & Johnson Innovation – JLABS, a premier life science incubator program. We envision rewriting medicine by bringing causality to cellular biology. As an AI-powered drug discovery biotech company, our primary mission is to develop cutting-edge engineered T cell therapies to combat solid tumors. Harnessing advancements in single-cell bioinformatics, machine learning and causal discovery, our team is developing a computational platform that provides a granular description of the heterogeneity of the tumor microenvironment (TME) and reclassifies patients by their unique TME signatures. Our platform will enable us to design potent T cell therapies by discovering the causal relationship between intracellular elements of T cells and their behaviors in patients' TME, surmounting the challenges presented by the complex nature of solid tumors and their microenvironments.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Synlico | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.